You can edit almost every page by Creating an account. Otherwise, see the FAQ.

Satish Mehta

From EverybodyWiki Bios & Wiki



Satish Mehta is the founder and CEO of Emcure Pharmaceuticals, an Indian multinational pharmaceutical company. He was born in a family of pharma retailers in Pune, India.[1] He is an alumnus of Pune University and Indian Institute of Management, Ahmedabad. Satish Mehta started Emcure in 1981 as a contract manufacturer and later started branded pharmaceuticals business.[2] He has been a member of committee to frame rules under the Indian Institutes of Management Act, 2017 – Ministry of HRD and Economic & Commercial Consultative Group (ECCG) – NITI Aayog, Govt. of India.[3] In 2017, Mehta was accused of artifically fixing high prices of generic medicines in the US.[4], [5]. Mehta also serves as a chairman of Gennova, an Indian biotechnology company that is developing mRNA vaccine supported by DBT-BIRAC[6] for COVID-19 in India.[7] He has been a member of committee to frame rules under the Indian Institutes of Management Act, 2017 – Ministry of HRD and Economic & Commercial Consultative Group (ECCG) – NITI Aayog, Govt. of India. He has 2 children who are part of management at Emcure.

[8]

References[edit]

  1. Oct 28, TNN |; 2003; Ist, 04:21. "A cure from Mr Mehta | undefined News - Times of India". The Times of India. Retrieved 2021-10-14.
  2. "Aim to take Emcure among top 5 pharma cos: MD". The Economic Times. Retrieved 2021-10-14.
  3. "Satish Mehta |Managing Director & Chief Executive Officer (CEO)| Emcure Pharmaceuticals". Emcure. Retrieved 2021-10-15.
  4. "U.S. states allege broad generic drug price-fixing collusion". Reuters. 2017-10-31. Retrieved 2021-10-14.
  5. Bloomberg, Abhineet Kumar & (2017-11-02). "Four pharma firms face US price-fixing charge". Business Standard India. Retrieved 2021-10-14.
  6. "DBT-BIRAC supported Nation's first mRNA-based vaccine found to be safe gets a nod from the Drugs Controller General of India DCG(I) to move into Phase II/III trial". www.pib.gov.in. Retrieved 2021-10-14.
  7. "Country's first mRNA vaccine safe, DCGI gives nod for phase 2/3 clinical trials". The Indian Express. 2021-08-24. Retrieved 2021-10-14.
  8. Shah, Sneha; Bhattacharyya, Rica. "Meet India's next generation of women leaders in pharma". The Economic Times. Retrieved 2021-10-14.

External Links[edit]

https://www.emcure.com/

https://gennova.bio/


This article "Satish Mehta" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Satish Mehta. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.